Study reveals mechanism by which malignant cells shut down anti-cancer immune responses

AI background business technology, digital transformation

A Ludwig Cancer Research study has revealed a single protein expressed at high levels by cancer cells across a broad range of malignancies that erects a multifaceted barrier to anti-cancer immune responses in mouse models of cancer and so shields tumors from immune detection and destruction.

5 of the best YouTube channels to learn about Native culture

Previous article

New approach for delivering medication across the blood-brain barrier to treat brain tumors

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News